Our advanced image analysis technology allows segmentation of lung structures like airways and blood vessels as well as detection of abnormalities in the lung parenchyma linked to multiple lung diseases.

The quantification of these segmentations allows to measure and follow-up the presence and the extent of conditions like COVID-19, influenza, ILDs, COPD, asthma, and others.